Muzaffar A, Brossi A, Lin C M, Hamel E
Medicinal Chemistry Section, NIDDK, National Institutes of Health, Bethesda, Maryland 20892.
J Med Chem. 1990 Feb;33(2):567-71. doi: 10.1021/jm00164a015.
Esterification of the phenolic group in 3-demethylthiocolchicine and exchange of the N-acetyl group with other N-acyl groups or a N-carbalkoxy group afforded many compounds which showed superior activity over the parent drug as inhibitors of tubulin polymerization and of the growth of L1210 murine leukemia cells in culture. A comparison of naturally occurring Colchicum alkaloids with thio isosters, obtained by replacing the OMe group at C(10) with a SCH3 group, showed the thio ethers to be invariably more potent in these assays. The comparison included 3-demethylthiodemecolcine prepared from 3-demethylthiocolchicine by partial synthesis. Thiation of thiocolchicine with Lawesson's reagent afforded novel thiotropolones which exhibited high antitubulin activity. Their structures are fully secured by spectral data. Colchicine and several of its analogues show good antitumor effect in mice infected with P388 lymphocytic leukemia, and all of them show high affinity for tubulin and inhibit tubulin polymerization at low concentration. Consequently, antitubulin assays with this class of compounds can serve as valuable prescreens for the initial evaluation of potential antitumor drugs.
对3-去甲基硫代秋水仙碱中的酚羟基进行酯化,并将N-乙酰基与其他N-酰基或N-烷氧羰基进行交换,得到了许多化合物,这些化合物作为微管蛋白聚合抑制剂和培养的L1210小鼠白血病细胞生长抑制剂,表现出比母体药物更强的活性。将天然存在的秋水仙属生物碱与通过将C(10)位的OMe基团替换为SCH3基团而获得的硫代异构体进行比较,结果表明硫醚在这些测定中始终具有更强的效力。该比较包括通过部分合成从3-去甲基硫代秋水仙碱制备的3-去甲基硫代地美秋水仙碱。用劳森试剂对硫代秋水仙碱进行硫代反应得到了具有高抗微管蛋白活性的新型硫代环庚三烯酚酮。它们的结构通过光谱数据得以完全确定。秋水仙碱及其几种类似物在感染P388淋巴细胞白血病的小鼠中显示出良好的抗肿瘤效果,并且它们都对微管蛋白具有高亲和力,并在低浓度下抑制微管蛋白聚合。因此,用这类化合物进行的抗微管蛋白测定可作为对潜在抗肿瘤药物进行初步评估的有价值的预筛选方法。